Search results for "PARKINSON DISEASE"

showing 10 items of 223 documents

Non-occlusive mesenteric Ischemia (NOMI) in Parkinson’s disease: Case report

2017

Non-occlusive mesenteric ischemia (NOMI) is a severe pathological condition characterized by signs and symptoms of bowel obstruction, intestinal necrosis resulting from acute and/or chronic inadequate blood perfusion, in the absence of an organic vascular obstruction detectable by imaging techniques. A 64 years old man case with a history of Parkinson’s disease in high-functioning levodopa treatment is presented. Clinical and radiological signs of intestinal obstruction were observed. He underwent surgical operation with total colectomy and terminal ileostomy for generalized secondary peritonitis due to perforation of sigmoid colon. Ischemic pancolitis was first suspected. In third post-o…

Malemedicine.medical_specialtyPancolitisNon-occlusive mesenteric ischemia (NOMI)medicine.medical_treatmentPerforation (oil well)Intestinal necrosiurologic and male genital diseasesGastroenterologyTotal colectomyClinical PracticeIleostomymedicine.arteryInternal medicineVasodilatormedicineHumansParkinson’s diseaseSuperior mesenteric arteryVeinBowel obstruction; Intestinal necrosis; Non-occlusive mesenteric ischemia (NOMI); Parkinson’s disease; Total colectomy; Vasodilators; Surgerybusiness.industrySigmoid colonParkinson DiseaseMiddle Agedmedicine.diseaseSurgeryBowel obstructionSettore MED/18 - Chirurgia Generalemedicine.anatomical_structureMesenteric ischemiaMesenteric IschemiaSurgerymedicine.symptombusinessTomography X-Ray ComputedIntestinal ObstructionBowel obstruction
researchProduct

Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease.

2009

Patients with Parkinson’s disease develop motor disturbances often accompanied by peripheral autonomic dysfunctions, including gastrointestinal disorders, such as dysphagia, gastric stasis and constipation. While the mechanisms subserving enteric autonomic dysfunctions are not clearly understood, they may involve the enteric dopaminergic and/or nitrergic systems. In the present study, we demonstrate that rats with unilateral 6-hydroxydopamine lesion of nigrostriatal dopaminergic neurons develop a marked inhibition of propulsive activity compared to sham-operated controls, as indicated by a 60% reduction of daily fecal output at the 4th week of observation. Immunohistochemical data revealed …

Malemedicine.medical_specialtyParkinson's diseaseColonGastrointestinal DiseasesCONSTIPATIONENTERIC NEURONSIleumBiologyNitric OxideEnteric Nervous SystemNOLesionRats Sprague-Dawleychemistry.chemical_compoundParkinsonian DisordersIleumInternal medicineNitrergic NeuronsmedicineAnimalsOxidopamineGUT DYSFUNCTIONNeuronal PlasticityGeneral NeuroscienceDopaminergicParkinson Diseasemedicine.diseaseImmunohistochemistryRatsDisease Models Animalmedicine.anatomical_structureEndocrinologychemistryCONSTIPATION; ENTERIC NEURONS; GUT DYSFUNCTION; NEUROPLASTICITY; NITRIC OXIDEEnteric nervous systemNeuronmedicine.symptomConstipation Enteric neurons Gut dysfunction Neuroplasticity Nitric oxideGastrointestinal MotilityNitrergic NeuronNEUROPLASTICITYOxidopamineNeuroscience letters
researchProduct

Elevation of striatal urate in experimental models of Parkinson's disease: a compensatory mechanism triggered by dopaminergic nigrostriatal degenerat…

2014

Epidemiological studies have indicated an inverse association between high uricemia and incidence of Parkinson's disease (PD). To investigate the link between endogenous urate and neurotoxic changes involving the dopaminergic nigrostriatal system, this study evaluated the modifications in the striatal urate levels in two models of PD. To this end, a partial dopaminergic degeneration was induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice, while a severe dopaminergic degeneration was elicited by unilateral medial forebrain bundle infusion of 6-hydroxydopamine (6-OHDA) in rats. Urate levels were measured by in vivo microdialysis at 7 or 14 days from toxin exposure. The resu…

Malemedicine.medical_specialtyParkinson's diseaseDopamineStriatumBiochemistryNeuroprotectionRats Sprague-DawleyCellular and Molecular Neurosciencechemistry.chemical_compoundHydroxydopaminesMiceDopamineInternal medicinemedicineAnimalsParkinson Disease SecondaryMedial forebrain bundleMPTPDopaminergic NeuronsNeurodegenerationDopaminergicMPTP Poisoningmedicine.diseaseRatsUric AcidMice Inbred C57BLNeostriatumSubstantia NigraEndocrinologynervous systemchemistryNeurosciencemedicine.drugJournal of neurochemistry
researchProduct

Implications for Estrogens in Parkinson's Disease: An Epidemiological Approach

2007

Abstract: Evidence from experimental and epidemiological studies suggests a role of sex hormones in the pathogenic process leading to neurodegenerative diseases, (i.e., Alzheimer's and Parkinson's disease). The effects of sexual steroid hormones are complex and vary with the events of women's fertile life. Estrogens are supposed to influence dopamine synthesis, metabolism, and transport; however, there is no consensus regarding the direction, locus, and mechanism of the effect of estrogens on the dopaminergic system. A neuroprotective effect of estrogens has been demonstrated in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-animal models of Parkinson's disease (PD). Epidemiological st…

Malemedicine.medical_specialtyParkinson's diseaseMenopause PrematureDiseaseBioinformaticsNeuroprotectionGeneral Biochemistry Genetics and Molecular Biologychemistry.chemical_compoundHistory and Philosophy of ScienceInternal medicinemedicineAnimalsHumansSex RatioLife lengthIncidenceGeneral NeuroscienceMPTPDopaminergicEstrogensParkinson Diseasemedicine.diseaseRatsMenopauseEndocrinologychemistryFemalePsychologyHormoneAnnals of the New York Academy of Sciences
researchProduct

Diabetes preceding Parkinson's disease onset. A case–control study

2009

Abstract Objective To assess the association between diabetes preceding Parkinson's disease (PD) and PD. Methods PD individuals were matched to PD free individuals randomly selected from people in the same municipality as the cases. Occurrence of diabetes preceding PD onset among cases and controls was assessed through a structured questionnaire. Information regarding current and past medical treatment and other variables was also collected. We used univariate and multivariate logistic models to calculate crude and adjusted odds ratios (OR). Covariates are adjusted for included education, smoking habit, alcohol and coffee consumption. Results 318 PD individuals (165 women, 153 men) and 318 …

Malemedicine.medical_specialtyParkinson's diseaseMultivariate analysiscase-control studyComorbidityDiseaseDiabeteRisk FactorsDiabetes mellitusInternal medicineEpidemiologyDiabetes MellitusmedicineHumansParkinson's Diseasebusiness.industryCase-control studyParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseNeurologyCase-Control StudiesSettore MED/26 - NeurologiaFemaleNeurology (clinical)Geriatrics and GerontologybusinessBody mass indexParkinsonism & Related Disorders
researchProduct

Prevalence and Profile of Mild Cognitive Impairment in Parkinson’s Disease

2011

<i>Background/Aims:</i> The frequency of mild cognitive impairment (MCI) in Parkinson’s disease (PD) ranges from 19 to 40%, and this is probably due to methodological differences between the studies. The aim of this study was to evaluate the frequency and profile of MCI in a large sample of nondemented PD subjects and neurologically healthy subjects (NHS). <i>Methods:</i> A total of 872 subjects (582 controls and 290 PD) were included. The association between MCI and PD was tested, using logistic regression models; odds ratios (OR) with 95% confidence intervals (CI) were calculated. <i>Results:</i> Fifty-three percent of PD subjects and 45% NHS met the cr…

Malemedicine.medical_specialtyParkinson's diseaseNeuropsychological TestsLogistic regressionInternal medicineEpidemiologyPrevalencemedicineHumansCognitive DysfunctionParkinson’s disease Cognitive impairment EpidemiologyCognitive impairmentAgedRetrospective StudiesHealthy subjectsParkinson DiseaseOdds ratioMiddle Agedmedicine.diseaseConfidence intervalLarge sampleLogistic ModelsNeurologyPhysical therapyFemaleSettore MED/26 - NeurologiaNeurology (clinical)PsychologyNeurodegenerative Diseases
researchProduct

Influence of visual cues on gait in Parkinson's disease during treadmill walking at multiple velocities.

2011

Abstract Objective To evaluate the interaction of different treadmill-induced gait velocities and visual cues on the gait performance in Parkinson's disease (PD). Background External cuing has been reported to facilitate hypokinetic gait patterns in PD. Methods 19 PD-patients and 17 controls volunteered for the study. Gait analyses were conducted using dynamic pressure sensors integrated in a treadmill at a given velocity of 1, 2, 3 or 4 km/h. For each velocity, measurements were performed under three conditions. The first condition was without visual cuing, the remaining two consisted of visual cuing e.g. white stripes put on the treadmill belt 25 or 50 cm apart. Results Visual cuing lower…

Malemedicine.medical_specialtyParkinson's diseasegenetic structuresErgometrySTRIDEWalkingTreadmill trainingTreadmill walkingPhysical medicine and rehabilitationmedicineHumansTreadmillSensory cueGaitAgedParkinson DiseaseMiddle Agedmedicine.diseaseGaitNeurologyCalibrationPhysical therapyFemaleNeurology (clinical)CuesPsychologyCadencehuman activitiesPhotic StimulationJournal of the neurological sciences
researchProduct

Effects of supervised slackline training on postural instability, freezing of gait, and falls efficacy in people with Parkinson's disease.

2016

The aim of this study was to assess whether supervised slackline training reduces the risk of falls in people with Parkinson's disease (PD).Twenty-two patients with idiopathic PD were randomized into experimental (EG, N = 11) and control (CG, N = 11) groups. Center of Pressure (CoP), Freezing of Gait (FOG), and Falls Efficacy Scale (FES) were assessed at pre-test, post-test and re-test. Rate perceived exertion (RPE, Borg's 6-20 scale) and local muscle perceived exertion (LRPE) were also assessed at the end of the training sessions.The EG group showed significant improvements in FOG and FES scores from pre-test to post-test. Both decreased at re-test, though they did not return to pre-test l…

Malemedicine.medical_specialtyParkinson's diseasemedicine.medical_treatmentFalls efficacyPostural instabilityPoison controlSeverity of Illness Index03 medical and health sciences0302 clinical medicineLumbarPhysical medicine and rehabilitationInjury preventionmedicineHumansExerciseGaitPostural BalanceFatigueAgedAged 80 and overRehabilitationbusiness.industryRehabilitationMotor controlParkinson Disease030229 sport sciencesFearMiddle Agedmedicine.diseaseExercise TherapyLower ExtremitySpainPhysical therapyAccidental FallsFemalebusiness030217 neurology & neurosurgeryDisability and rehabilitation
researchProduct

6-Hydroxydopamine lesioning differentially affects α-synuclein mRNA expression in the nucleus accumbens, striatum and substantia nigra of adult rats

2002

The effect of a unilateral 6-hydroxydopamine (6-OHDA) lesion and/or repeated administration of levodopa (L-DOPA) to normal and 6-OHDA-lesioned rats on alpha-synuclein mRNA expression was investigated by in situ hybridization histochemistry. A 6-OHDA lesion of the nigro-striatal pathway alone, confirmed by the loss of nigral tyrosine hydroxylase mRNA expression, markedly decreased alpha-synuclein mRNA in the lesioned substantia nigra (SN). In contrast, the levels of alpha-synuclein mRNA in the denervated striatum and nucleus accumbens were not altered. Chronic administration of L-DOPA to normal or 6-OHDA-lesioned rats had no effect on alpha-synuclein mRNA expression in the SN, striatum or nu…

Malemedicine.medical_specialtyTyrosine 3-MonooxygenaseDopamineanimal diseasesDopamine AgentsSynucleinsNerve Tissue ProteinsSubstantia nigraStriatumNucleus accumbensBiologyDrug Administration ScheduleNucleus Accumbenschemistry.chemical_compoundDopamineInternal medicineBasal gangliamedicineAnimalsTyrosine hydroxylase mRNARNA MessengerRats WistarOxidopamineNeuronsHydroxydopamineTyrosine hydroxylaseGeneral NeuroscienceParkinson Diseaseα-Synuclein mRNARatsnervous system diseasesNeostriatumSubstantia NigraEndocrinologynervous systemchemistrySympatholyticsalpha-SynucleinSettore BIO/14 - Farmacologia6-HydroxydopamineOxidopaminemedicine.drugNeuroscience Letters
researchProduct

A Nomogram to Characterize the Severity of Detrusor Overactivity during the Ice Water Test: Description of the Method and Proof of Concept

2017

<b><i>Aims:</i></b> To develop a nomogram with severity categories for detrusor overactivity (DO). <b><i>Methods:</i></b> By conducting ice water tests (IWT) in 55 patients with Parkinson’s disease, we identified criteria to describe characteristics of the detrusor pressure curves: (1) a gradient of Δ<i>pdet</i> over Δt at the maximum detrusor pressure and (2) the area under the curve. In a nomogram, 10 severity categories of DO were established: 1 and 2 were assigned to group A (mild), 3 and 4 to group B (moderate) and 5–10 to group C (severe). <b><i>Results:</i></b> In the nomogram, negative IWT (20) appea…

Malemedicine.medical_specialtygenetic structuresUrologyUrinary Bladder030232 urology & nephrologyUrologyurologic and male genital diseasesProof of Concept Study03 medical and health sciences0302 clinical medicinemedicineHumansUrinary Bladder NeurogenicAgedUrinary Bladder Overactivebusiness.industryArea under the curveReproducibility of ResultsParkinson DiseaseMiddle AgedNomogramIce waterNomogramsUrodynamicsAdministration IntravesicalUrinary Incontinence030220 oncology & carcinogenesisDetrusor pressureFemalebusinessUrologia Internationalis
researchProduct